
Alcon claims control of cell therapy firm Aurion
Eyecare giant Alcon has bought a majority stake in cell therapy start-up Aurion Biotech, replacing the company's chief executive, in the culmination of a months-long struggle for control. In a statement, Alcon said it plans for Aurion to continue as a …